Home / Biosimilars

Biosimilars

News

ST002293 Japanese approval for first adalimumab biosimilar posted 03/07/2020

Japan-based Fujifilm Kyowa Kirin Biologics announced on 29 June 2020 that it had received approval from Japan’s medicines reg...

EC approval for etanercept biosimilar Nepexto posted 03/07/2020

The European Commission (EC) has granted marketing authorization for the etanercept biosimilar Nepexto (YLB113), developed by...

China approves bevacizumab copy biological Byvasda posted 26/06/2020

China-based drugmaker Innovent Biologics (Innovent) announced on 19 June 2020 that China’s National Medical Products Administ...

Canada approves pegfilgrastim biosimilar Ziextenzo posted 26/06/2020

Canada’s drug regulator, Health Canada, has approved the pegfilgrastim biosimilar Ziextenzo (LA-EP2006). The drug can be used...

FDA approves insulin glargine biosimilar Semglee posted 24/06/2020

US-based drugmaker Mylan and partner, India-based biologicals specialist Biocon, announced on 11 June 2020 that it had receiv...

 

Research

Biosimilars in Belgium: increasing competition posted 03/07/2020

Competition following the entry of biosimilars is still limited in Belgium, which is mirrored in low biosimilar market shares...

Positive phase I results for Innovent’s ipilimumab copy biological posted 03/07/2020

China-based Innovent Biologics (Innovent) announced on 3 June 2020 positive phase I results for its candidate ipilimumab copy...

Successfully transitioning patients with IBD to biosimilars posted 26/06/2020

Pharmacists and physicians from the Boston Medical Center describe the successful transition of patients with inflammatory bo...

EULAR recommendations for DMARDs in rheumatoid arthritis posted 26/06/2020

The European League Against Rheumatism (EULAR) has updated its recommendations on the management of rheumatoid arthritis (RA)...

22119008_l Positive phase Ib results for TYVYT + bevacizumab copy biological IBI305 posted 19/06/2020

China-based Innovent Biologics (Innovent) announced on 1 June 2020 positive results for a phase I trial of its candidate beva...

 

General

Medscape hosts virtual symposium on biosimilars in IBD posted 03/07/2020

Medscape held a virtual symposium on the use of biosimilars in inflammatory bowel disease (IBD) on 30 May 2020. The event cov...

Switching from biologicals to biosimilars in Australia posted 03/07/2020

Switching* patients from originator biologicals to biosimilars has been a topic of keen interest in recent years across the g...

ISOPP publishes a whole host of information on biosimilars posted 03/07/2020

The International Society of Oncology Pharmacy Practitioners (ISOPP) has published a whole host of information on biosimilars...

WHO prequalifies first rituximab biosimilar posted 03/07/2020

The World Health Organization (WHO) has prequalified its first rituximab biosimilar as part of its efforts to make life-savin...

Biosimilar Awareness Week in Australia posted 03/07/2020

The second Biosimilar Awareness Week took place on 25–29 May 2020 in Australia. It involved discussion on social media and ai...